Hims & Hers Health
HIMS
244 hedge funds and large institutions have $1.97B invested in Hims & Hers Health in 2024 Q1 according to their latest regulatory filings, with 82 funds opening new positions, 70 increasing their positions, 66 reducing their positions, and 33 closing their positions.
188% more call options, than puts
Call options by funds: $59.1M | Put options by funds: $20.5M
148% more first-time investments, than exits
New positions opened: 82 | Existing positions closed: 33
76% more capital invested
Capital invested by funds: $1.12B → $1.97B (+$850M)
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
24% more funds holding
Funds holding: 197 → 244 (+47)
6% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 66
0.07% more ownership
Funds ownership: 61.9% → 61.97% (+0.07%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Voloridge Investment Management
Jupiter,
Florida
|
+$27.6M |
| 2 |
Renaissance Technologies
New York
|
+$24.6M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$23.4M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$20M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$18.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IVMX
Institutional Venture Management XV
Menlo Park,
California
|
-$28.2M |
| 2 |
IVMX
Institutional Venture Management XVI
Menlo Park,
California
|
-$28.2M |
| 3 |
RM
Redpoint Management
Woodside,
California
|
-$28.2M |
| 4 |
Millennium Management
New York
|
-$13.4M |
| 5 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$10.7M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FWA
276
FSC Wealth Advisors
Fishkill,
New York
| – | -$445 | -50 | Closed |
|
277
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$45 | -5 | Closed |
|
HIMS Hedge Fund Activity: Q1 2024 in Review
244 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health (HIMS) for Q1 2024, worth a combined $1.97B — up 76% from $1.12B a quarter earlier.
Buyers outnumbered sellers: 82 funds opened new HIMS positions and 33 closed out — a net gain of 49 holders — while 70 added to existing stakes and 66 trimmed.
The largest buyer was Voloridge Investment Management, adding an estimated $27.6M. The largest seller was Institutional Venture Management XV, cutting an estimated $28.2M.
- 244 institutional investors held Hims & Hers Health (HIMS) as of Q1 2024, up from 197 in Q4 2023.
- Funds reported $1.97B of Hims & Hers Health stock for Q1 2024, up 76% quarter-over-quarter.
- 82 funds opened new Hims & Hers Health positions in Q1 2024 and 33 closed out, a net change of +49 holders.
- The largest Hims & Hers Health buyer in Q1 2024 was Voloridge Investment Management, an estimated $27.6M added.
- The largest Hims & Hers Health seller in Q1 2024 was Institutional Venture Management XV, an estimated $28.2M sold.
Based on aggregated 13F filings for Q1 2024.